Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 113, Issue 9, Pages 1301-1309Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41395-018-0146-0
Keywords
-
Categories
Ask authors/readers for more resources
Over the course of the last 2 decades our knowledge of autoimmune pancreatitis has increased exponentially. In this review, we summarize the clinical presentation, diagnosis and treatment of AIP, to better allow general gastroenterologists and primary care providers to consider AIP as a as a rare but important cause of painless obstructive jaundice and recurrent acute pancreatitis. While steroids remain the mainstay of first line therapy, a number of patients with type 1 AIP require immunomodulators or rituximab to maintain remission; recommendations on the management of relapses continue to evolve.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available